Go Pro

Wedge Capital Management L L P NC Acquires 23,315 Shares of Amdocs Limited $DOX

Amdocs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Wedge Capital Management increased its Amdocs stake by 39.2% in the second quarter, acquiring 23,315 additional shares and bringing its holdings to 82,765 shares valued at approximately $4.18 million. Institutional investors own 92.02% of the company.
  • Analyst sentiment is mixed, with three Buy, three Hold and one Sell rating. Amdocs has a consensus rating of Hold and an average price target of $86.67.
  • Amdocs reported quarterly earnings of $1.84 per share, matching estimates, while revenue rose 2.7% year over year to $1.17 billion. The company also declared a quarterly dividend of $0.569 per share, representing a 3.9% annualized yield.
  • MarketBeat previews the top five stocks to own by September 1st.

Wedge Capital Management L L P NC grew its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 39.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 82,765 shares of the technology company's stock after purchasing an additional 23,315 shares during the quarter. Wedge Capital Management L L P NC owned about 0.08% of Amdocs worth $4,183,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of the business. WealthCollab LLC lifted its position in shares of Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company's stock worth $29,000 after buying an additional 173 shares during the last quarter. BOK Financial Private Wealth Inc. bought a new position in shares of Amdocs in the 4th quarter valued at approximately $37,000. Los Angeles Capital Management LLC acquired a new stake in Amdocs in the 4th quarter worth approximately $39,000. Advisory Services Network LLC bought a new stake in Amdocs during the third quarter worth approximately $42,000. Finally, CIBC Private Wealth Group LLC grew its holdings in Amdocs by 190.2% during the third quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company's stock valued at $49,000 after purchasing an additional 390 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. KeyCorp assumed coverage on shares of Amdocs in a report on Monday, June 29th. They set a "sector weight" rating for the company. Stifel Nicolaus decreased their price target on shares of Amdocs from $88.00 to $71.00 and set a "buy" rating for the company in a report on Thursday, May 14th. Cfra downgraded Amdocs to a "sell" rating in a research report on Thursday, May 14th. Wall Street Zen lowered Amdocs from a "buy" rating to a "hold" rating in a research note on Sunday, July 5th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Amdocs in a research report on Wednesday, August 5th. Three equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $86.67.

Get Our Latest Analysis on DOX

Amdocs Stock Up 2.4%

Shares of DOX opened at $58.66 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.98 and a current ratio of 0.94. The company has a 50-day simple moving average of $54.05 and a 200-day simple moving average of $62.46. Amdocs Limited has a 52 week low of $49.74 and a 52 week high of $88.47. The firm has a market capitalization of $6.33 billion, a P/E ratio of 13.97, a P/E/G ratio of 1.00 and a beta of 0.40.

Amdocs (NASDAQ:DOX - Get Free Report) last released its earnings results on Wednesday, August 5th. The technology company reported $1.84 earnings per share for the quarter, hitting analysts' consensus estimates of $1.84. Amdocs had a return on equity of 20.28% and a net margin of 9.75%.The business had revenue of $1.17 billion for the quarter, compared to the consensus estimate of $1.18 billion. During the same period last year, the business earned $1.72 earnings per share. The firm's revenue for the quarter was up 2.7% compared to the same quarter last year. Amdocs has set its Q4 2026 guidance at 1.940-2.000 EPS and its FY 2026 guidance at 7.374-7.444 EPS. On average, equities research analysts expect that Amdocs Limited will post 6.56 earnings per share for the current year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a dividend yield of 3.9%. The ex-dividend date of this dividend is Wednesday, September 30th. Amdocs's dividend payout ratio (DPR) is presently 54.29%.

Amdocs Company Profile

(Free Report)

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

Featured Articles

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines